ArticleScientific reports2017

Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.

María Carmen Leiva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.